Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 17 April 1998:
Vol. 280. no. 5362, p. 379
DOI: 10.1126/science.280.5362.379

Research News

MICROBIOLOGY:
A Possible New Approach to Combating Staph Infections

Evelyn Strauss

Roughly one-third of the strains of the dangerous pathogen Staphylococcus aureus currently being isolated from hospital infections are now resistant to all antibiotics but one, vancomycin--and resistance to that antibiotic has begun cropping up. But new research suggests an approach to combating S. aureus, which causes infections ranging from skin abscesses to such life-threatening conditions as pneumonia, septicemia, and toxic shock syndrome, that may sidestep the organism's ability to develop resistance. On page 438, infectious-disease researchers report that they can decrease the incidence and severity of S. aureus infections in mice by blocking the activity of a protein called RAP, which controls the production of toxins and other proteins that make the bacterium pathogenic. Although the work is still in its early stages, it suggests that disabling RAP might keep the microbe from spreading within the body before the patient's immune system flushes it out.

Read the Full Text





To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)